Abstract: A melanin synthesis inhibiting agent or skin lightening agent comprising pyranocoumarin derivatives as the melanin synthesis inhibitory active and cosmetic and dermopharmaceutical compositions comprising the same. More specifically, the present invention provides simple and cost effective skin care benefiting agents comprising pyranocoumarin derivative as an active ingredient selected from seselin of Formula 1 which can be used singly or in combination with cosmetically/ dermopharmaceutically acceptable vehicle/ carriers.
| # | Name | Date |
|---|---|---|
| 1 | 0954-CHE-2011 DESCRIPTION(COMPLETE) 28-03-2011.pdf | 2011-03-28 |
| 1 | 954-CHE-2011-AbandonedLetter.pdf | 2018-01-10 |
| 2 | 954-CHE-2011-FER.pdf | 2017-06-21 |
| 2 | 0954-CHE-2011 CLAIMS 28-03-2011.pdf | 2011-03-28 |
| 3 | 954-CHE-2011 CORRESPONDENCE OTHERS 23-11-2012.pdf | 2012-11-23 |
| 3 | 0954-CHE-2011 ABSTRACT 28-03-2011.pdf | 2011-03-28 |
| 4 | 954-CHE-2011 FORM.18 23-11-2012.pdf | 2012-11-23 |
| 4 | 0954-CHE-2011 POWER OF ATTORNEY 28-03-2011.pdf | 2011-03-28 |
| 5 | 0954-CHE-2011 CORRESPONDENCE OTHERS 28-03-2011.pdf | 2011-03-28 |
| 5 | 0954-CHE-2011 FORM-3 28-03-2011.pdf | 2011-03-28 |
| 6 | 0954-CHE-2011 FORM-1 28-03-2011.pdf | 2011-03-28 |
| 6 | 0954-CHE-2011 FORM-2 28-03-2011.pdf | 2011-03-28 |
| 7 | 0954-CHE-2011 FORM-1 28-03-2011.pdf | 2011-03-28 |
| 7 | 0954-CHE-2011 FORM-2 28-03-2011.pdf | 2011-03-28 |
| 8 | 0954-CHE-2011 CORRESPONDENCE OTHERS 28-03-2011.pdf | 2011-03-28 |
| 8 | 0954-CHE-2011 FORM-3 28-03-2011.pdf | 2011-03-28 |
| 9 | 0954-CHE-2011 POWER OF ATTORNEY 28-03-2011.pdf | 2011-03-28 |
| 9 | 954-CHE-2011 FORM.18 23-11-2012.pdf | 2012-11-23 |
| 10 | 954-CHE-2011 CORRESPONDENCE OTHERS 23-11-2012.pdf | 2012-11-23 |
| 10 | 0954-CHE-2011 ABSTRACT 28-03-2011.pdf | 2011-03-28 |
| 11 | 954-CHE-2011-FER.pdf | 2017-06-21 |
| 11 | 0954-CHE-2011 CLAIMS 28-03-2011.pdf | 2011-03-28 |
| 12 | 954-CHE-2011-AbandonedLetter.pdf | 2018-01-10 |
| 12 | 0954-CHE-2011 DESCRIPTION(COMPLETE) 28-03-2011.pdf | 2011-03-28 |
| 1 | 954che2011_20-06-2017.pdf |